NEW YORK (TheStreet) -- Shares of Medical Properties Trust  (MPW - Get Report) are retreating 0.39% to $15.15 in pre-market trading on Friday after JMP Securities reduced its rating on shares to "market perform" from "market outperform."

The Birmingham, AL-based real estate investment trust is focused on investing in and owning net-leased healthcare facilities.

The downgrade comes as the stock exceeded JMP's former price target of $14, which the firm removed.

"MPW shares are fairly valued at current levels with the company's improved leverage and opportunities for outsized yields in the hospital sector. MPW shares are up 20.0% over the last three months versus the S&P 500 and Healthcare REIT sector group up 0.5% and 10.1%, respectively," the firm wrote in an analyst note this morning.

The healthcare REIT sector has outperformed in recent months given rising macroeconomic and geopolitical concerns, which have pushed more capital to a defensive posture, JMP noted.

Separately, TheStreet Ratings Team has a "Buy" rating with a score of B on the stock.

The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and attractive valuation levels. 

Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.

You can view the full analysis from the report here: MPW